Profiel
Daniel Getts is the founder of Cour Pharmaceuticals Development Co., Inc.,CREATE Medicines, Inc. (Massachusetts).
Dr. Getts is currently Director at Curate Biosciences since 2022.
Formerly, Dr. Getts was Director-Research & Development at Tolera Therapeutics, Inc. and Vice President-Research at TCR² Therapeutics, Inc. from 2017 to 2019.
Dr. Getts earned a doctorate from Northwestern University and both a graduate degree and a doctorate from The University of Sydney.
Actieve functies van Daniel Getts
| Bedrijven | Functie | Begin |
|---|---|---|
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Oprichter | - |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Directeur/Bestuurslid | 15-08-2022 |
Eerdere bekende functies van Daniel Getts
| Bedrijven | Functie | Einde |
|---|---|---|
| TCR2 THERAPEUTICS INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2019 |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Oprichter | - |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Corporate Officer/Principal | - |
Opleiding van Daniel Getts
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Northwestern University
Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Sydney
The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tolera Therapeutics, Inc.
Tolera Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapies and technologies for immune modulation | Commercial Services |
Curate Biosciences
Curate Biosciences Miscellaneous Commercial ServicesCommercial Services Provides medical research and cell separation services | Commercial Services |
Cour Pharmaceuticals Development Co., Inc.
Cour Pharmaceuticals Development Co., Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes biopharmaceuticals to treat autoimmune diseases | Health Technology |
TCR2 Therapeutics, Inc.
TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
















